The Development of Multi-epitope Vaccines: Epitope Identification, Vaccine Design and Clinical Evaluation
- 1 September 2001
- journal article
- Published by Elsevier in Biologicals
- Vol. 29 (3-4) , 271-276
- https://doi.org/10.1006/biol.2001.0297
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Optimization of epitope processing enhances immunogenicity of multiepitope DNA vaccinesVaccine, 2001
- Identification and Antigenicity of Broadly Cross-Reactive and Conserved Human Immunodeficiency Virus Type 1-Derived Helper T-Lymphocyte EpitopesJournal of Virology, 2001
- Definition of the Mamu A*01 Peptide Binding Specificity: Application to the Identification of Wild-Type and Optimized Ligands from Simian Immunodeficiency Virus Regulatory ProteinsThe Journal of Immunology, 2000
- Quantifying the uncertainty in forecasts of anthropogenic climate changeNature, 2000
- Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphismImmunogenetics, 1999
- Human histocompatibility leukocyte antigen-binding supermotifs predict broadly cross-reactive cytotoxic T lymphocyte responses in patients with acute hepatitis.Journal of Clinical Investigation, 1997
- Practical, biochemical and evolutionary implications of the discovery of HLA class I supermotifsImmunology Today, 1996
- Differences and similarities in the A2.1‐restricted cytotoxic T cell repertoire in humans and human leukocyte antigen‐transgenic miceEuropean Journal of Immunology, 1996
- In vitro induction of primary, antigen-specific CTL from human peripheral blood mononuclear cells stimulated with synthetic peptidesMolecular Immunology, 1995
- Prediction of major histocompatibility complex binding regions of protein antigens by sequence pattern analysis.Proceedings of the National Academy of Sciences, 1989